Clinical Trial Update: MRA With Feraheme in HHT [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating MRA in combination with Feraheme (ferumoxytol) for hereditary hemorrhagic telangiectasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Hemorrhagic Telangiectasia

Drugs mentioned

• Feraheme (ferumoxytol)
• MRA (MRA)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Hereditary Hemorrhagic Telangiectasia | Phase 1 | Status: COMPLETED